# Cost-Sharing and Buprenorphine Prescription Dispensing

## TL;DR

This study examines how out-of-pocket costs affect the dispensing of buprenorphine, a medication used for opioid use disorder, among patients with commercial and Medicare insurance.

## Contribution

The study provides new evidence on how cost-sharing impacts buprenorphine prescription dispensing in different insurance groups.

## Key findings

- Higher cost-sharing is associated with lower rates of buprenorphine dispensing.
- The effect of cost-sharing on dispensing varies between commercially insured and Medicare-insured patients.

## Abstract

This cross-sectional study estimates the association between cost-sharing and buprenorphine dispensing among commercially insured and Medicare-insured patients.